6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T21505 | Suberoyl bis-hydroxamic acid | SBHA,Suberohydroxamic acid | Apoptosis , HDAC |
Suberoyl bis-hydroxamic acid (SBHA) is a Histone deacetylase (HDAC) inhibitor. HDAC is required for transcriptional modulation, cell cycle regulation and development. It is an enzyme that deacetylates lysine residues on ... | |||
T0134 | Imiquimod | R 837,S-26308 | SARS-CoV , TLR , Autophagy , HSV |
Imiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist. | |||
T35182 | Xinidamine | BRN 0891979,Xinidaminum,Xinidamino | |
Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells w... | |||
T67786 | ABI-1968 PM | ||
ABI-1968 PM is a derivative of ABI-1968, an apoptosis-stimulating agent and an inhibitor of viral replication.ABI-1968 can be used to study cervical intraepithelial neoplasia, papillomavirus infection, and squamous intra... | |||
T1033L | Monensin | Elancoban,Rumensin | |
Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with d... | |||
T68306 | INCB16562 | ||
INCB16562 is a novel, selective, and orally bioavailable small-molecule inhibitor of JAK1 and JAK2 markedly selective over JAK3. Treatment of myeloma cells with INCB16562 potently inhibited interleukin-6 (IL-6)-induced p... |